| Dose Ranging Study of Pazopanib to Treat Neovascular Age-Related Macular Degeneration (NCT01134055) | GlaxoSmithKline | 2010-06-01 |
| Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMD (NCT01021956) | Steba Biotech S.A. | 2010-06-01 |
| Efficacy Study of Ranibizumab on Patients With Age-related Macular Degeneration. (NCT01831947) | Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH | 2010-04-01 |
| A Safety Study to Evaluate Pazopanib Eye Drops in Healthy Volunteers (NCT01072214) | GlaxoSmithKline | 2010-03-09 |
| A Safety Study in Healthy Volunteers to Evaluate Safety, How Fast the Drug is Absorbed, and the Side Effects of the Drug in Humans (NCT01051700) | GlaxoSmithKline | 2010-01-12 |
| Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD) (NCT01024998) | Genzyme, a Sanofi Company | 2010-01-11 |
| Genetics in Non-response to Anti-VEGF Treatment in Exudative AMD (NCT01213667) | University of Cologne | 2010-01-01 |
| INTREPID - IRay Plus Anti-VEGF Treatment For Patients With Wet AMD (NCT01016873) | Oraya Therapeutics, Inc. | 2009-11-01 |
| Macular EpiRetinal Brachytherapy Versus Lucentis® Only Treatment (MERLOT) (NCT01006538) | King's College Hospital NHS Trust | 2009-11-01 |
| Lucentis in Advanced Macular Degeneration (NCT00896779) | Steven R. Sanislo | 2009-10-01 |
| Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration (NCT00996684) | University of California, Los Angeles | 2009-10-01 |
| Does Complement Factor H Gene Polymorphism Play a Role in the Regulation of Vascular Tone in the Choroid? (NCT00708929) | Medical University of Vienna | 2009-06-01 |
| Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration (NCT00877032) | Pfizer | 2009-04-01 |
| Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD) (NCT00745511) | Ora Bio Ltd. | 2009-03-01 |
| Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration (NCT00813891) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2009-01-01 |
| Long-Term Use Of Pegaptanib In Patients For Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration (NCT00845273) | Pfizer | 2008-11-01 |
| Macugen Observational Study (NCT00735943) | Pfizer | 2008-11-01 |
| Pilot Study: A Randomized Trial Of Anesthetic Agents For Intravitreal Injection (NCT00769392) | Lahey Clinic | 2008-09-01 |
| Safety & Tolerability of the IRay System in Subjects With Exudative Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) (NCT01217762) | Oraya Therapeutics, Inc. | 2008-07-01 |
| VEGF-antagonism and Endothelial Function in Age-related Macular Degeneration (AMD) (NCT00727753) | University of Zurich | 2008-07-01 |
| An Extension to Study MD7108240 (NCT00733304) | GlaxoSmithKline | 2008-06-25 |
| Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV) (NCT00695682) | Retina Research Foundation | 2008-06-01 |
| Safety and Efficacy of Brimonidine Intravitreal Implant in Patients With Geographic Atrophy Due to Age-related Macular Degeneration (AMD) (NCT00658619) | Allergan | 2008-05-01 |
| An Open Study Comparing the Effects of Moxaverine on Ocular Blood Flow in Patients With Age- Related Macular Degeneration, Primary Open Angle Glaucoma and Healthy Control Subjects (NCT00709449) | Medical University of Vienna | 2008-05-01 |
| High Speed Indocyanine Green Angiography Findings in Ranibizumab Treatment for Wet Age-related Macular Degeneration (NCT00656903) | National Eye Institute (NEI) | 2008-04-07 |
| Study Of The Repeat Dosing Of Ketoconazole On The Pharmacokinetics Of A Single Dose Of Pazopanib (GW786034) Eye Drops (NCT00659555) | GlaxoSmithKline | 2008-04-04 |
| Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD) (NCT00637377) | Bayer | 2008-04-01 |
| To Evaluate the Pharmacodynamics, Safety, and Pharmacokinetics of Pazopanib Drops in Adult Subjects With Neovascular AMD (NCT00612456) | GlaxoSmithKline | 2008-03-05 |
| The Effect of a Single Intravitreal Anti-VEGF Therapy on Optic Nerve Head Perfusion (NCT00709657) | Medical University of Vienna | 2008-03-01 |
| Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab or Ranibizumab (NCT00605943) | National Eye Institute (NEI) | 2008-01-16 |
| VEGF Gene Association With Response to Neovascular Age-related Macular Degeneration With Anti-VEGF Agents (NCT01655589) | Institute of Vision, Brasil | 2008-01-01 |
| Potential Research Participants for Future Studies of Inherited Eye Diseases (NCT00559234) | National Eye Institute (NEI) | 2007-11-09 |
| Intravitreal Bevacizumab Combined With PDT Versus Bevacizumab to Treat Exudative AMD (NCT00684853) | Federal University of São Paulo | 2007-11-01 |
| Subretinal Lucentis for Hemorrhagic Age-related Macular Degeneration (AMD) (NCT00538538) | Corewell Health East | 2007-09-01 |
| Evaluation of Dosing Interval of Higher Doses of Ranibizumab (NCT00533520) | Brandon G. Busbee, MD | 2007-09-01 |
| A Phase 1 Safety Study of Single and Repeated Doses of JSM6427 (Intravitreal Injection) to Treat AMD (NCT00536016) | Jerini Ophthalmic | 2007-09-01 |
| Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (NCT00499590) | OPKO Health, Inc. | 2007-08-01 |
| Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD) (NCT00509795) | Regeneron Pharmaceuticals | 2007-08-01 |
| Randomized, Single-Masked, Long-Term, Safety and Tolerability Study of VEGF Trap-Eye in AMD (NCT00527423) | Regeneron Pharmaceuticals | 2007-08-01 |
| Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL) (NCT00492284) | QLT Inc. | 2007-07-01 |
| Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMD (NCT00509548) | TargeGen | 2007-07-01 |
| A Study of Genetic and Environmental Factors and Their Effect on Response to Treatment With Lucentis (Ranibizumab) for Wet AMD (NCT00469352) | Oregon Health and Science University | 2007-05-01 |
| Ranibizumab and Reduced Fluence PDT for AMD (NCT00527475) | Texas Retina Associates | 2007-05-01 |
| The Effect of Intravitreal Avastin on the Retina Measured by Electroretinogram (NCT00478530) | Sheba Medical Center | 2007-05-01 |
| Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD) (NCT00433017) | Novartis | 2007-05-01 |
| The Optical Coherence Tomography in Age-Related Macular Degeneration Study: The OCT in AMD Study (NCT00531141) | The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery | 2007-05-01 |
| A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration (NCT00454389) | NeoVista | 2007-04-01 |
| Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD) (NCT00414206) | CoMentis | 2007-03-01 |
| Combination Therapy for Neovascular Age Related Macular Degeneration (NCT00447031) | Yonsei University | 2007-03-01 |
| Influence of Blue Light Filtering Intraocular Lenses on Daytime Levels of Melatonin (NCT00444249) | The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery | 2007-03-01 |
| Scotoma Reduction in AMD Patients Treated With Ranibizumab (NCT00467935) | Retina Research Foundation | 2007-03-01 |
| A Study To Evaluate The Safety, Tolerability And Pk Of Pazopanib Eye Drops In Healthy Adult And Elderly Subjects. (NCT00463320) | GlaxoSmithKline | 2007-03-01 |
| Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (NCT00436553) | Novartis | 2007-02-01 |
| Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD) (NCT00051129) | Alcon Research | 2007-01-01 |
| Photodynamic and Pharmacologic Treatment of CNV (NCT00570193) | Mid-Atlantic Retina Consultations, Inc. | 2006-12-01 |
| Oxidative Stress in Patients With Age-Related Macular Degeneration (NCT00465400) | University Hospital, Basel, Switzerland | 2006-11-01 |
| A Phase 1 Safety Study of TG100801 Eye Drops in Healthy Volunteers (NCT00414999) | TargeGen | 2006-11-01 |
| Bevacizumab in Combination With Verteporfin Reduced and Standard Fluence in the Treatment of Hemorrhaged Lesions in Neovascular AMD (NCT00403442) | Vitreous -Retina- Macula Consultants of New York | 2006-09-01 |
| Copaxone in Age Related Macular Degeneration (NCT00466076) | Kaplan Medical Center | 2006-08-01 |
| Ocular Safety Of Patients Receiving Macugen For Neovascular Age Related Macular Degeneration (NCT00460408) | Pfizer | 2006-08-01 |
| Observational Study Of The Long-Term Effect Of Macugen In Patients With Wet Age-Related Macular Degeneration (NCT01245387) | Pfizer | 2006-08-01 |
| Phase II Pilot Study of Visudyne® Photodynamic Therapy (PDT) (Low and Very Low Fluence) Combined With Bevacizumab. (NCT00359164) | University of British Columbia | 2006-07-01 |
| Evaluation Of Safety And Efficacy Of 0.3 Mg/Eye Macugen In Patients With Small Age-Related Macular Degeneration Lesions (NCT00324116) | Pfizer | 2006-07-01 |
| An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD (NCT00327470) | Pfizer | 2006-07-01 |
| Alprostadil in Maculopathy Study (AIMS) (NCT00619229) | UCB Pharma | 2006-07-01 |
| Antioxidant Systems and Age-Related Macular Degeneration (NCT00668213) | Vanderbilt University | 2006-06-01 |
| A Long-Term Monitoring Study of the IMT-002 Patients (NCT00976235) | VisionCare, Inc. | 2006-06-01 |
| A Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration (NCT00333476) | Genaera Corporation | 2006-05-01 |
| Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD) (NCT00320788) | Regeneron Pharmaceuticals | 2006-04-01 |
| Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD (NCT00426998) | Retinal Consultants Medical Group | 2006-04-01 |
| A Clinical Trial to Explore the Safety and Efficacy of Three Different Doses of Pegaptanib Sodium in Patients With Wet Age-Related Macular Degeneration (AMD) (NCT00312351) | Eyetech Pharmaceuticals | 2006-04-01 |
| Clinical and Genetic Analyzes of Age-related Macular Degeneration (NCT03614481) | Centre Hospitalier Intercommunal Creteil | 2005-11-01 |
| Long-Term Efficacy in AMD of Rheopheresis in North America (NCT00380172) | OccuLogix | 2005-10-01 |
| Double-Masked Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Age-Related Macular Degeneration (NCT00157976) | Miravant Pharmaceuticals | 2005-09-01 |
| A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib (NCT00242580) | Novartis Pharmaceuticals | 2005-09-01 |
| Clinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular Degeneration (NCT00239928) | Pfizer | 2005-09-01 |
| Treatment of Age-Related Macular Degeneration With Anecortave Acetate (NCT00211458) | Manhattan Eye, Ear & Throat Hospital | 2005-09-01 |
| Comparison of Reduced Fluence Versus Standard Photodynamic Therapy (in Combination With Intravitreal Triamcinolone Acetate) (NCT00523406) | Medical University of Vienna | 2005-08-01 |
| Study To Determine Safety/Efficacy of Lucentis For Treatment Of Retinal Angiomatous Proliferation Secondary To Age Related Macular Degeneration (NCT00395707) | The National Retina Institute | 2005-08-01 |
| Systemic Avastin Therapy in Age-Related Macular Degeneration (NCT00531024) | The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery | 2005-08-01 |
| Lutein/Zeaxanthin and Omega-3 Supplementation in Persons Over Age 60 (NCT00121589) | National Eye Institute (NEI) | 2005-07-14 |
| Safety and Efficacy Study of Small Interfering Ribonucleic Acid (RNA) Molecule (Cand5) to Treat Wet Age-Related Macular Degeneration (NCT00259753) | OPKO Health, Inc. | 2005-07-01 |
| Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD (NCT00320775) | Regeneron Pharmaceuticals | 2005-06-01 |
| Anecortave Acetate in Patients With Exudative Age-related Macular Degeneration (AMD) (NCT00299507) | Alcon Research | 2005-03-01 |
| Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular Degeneration (NCT00100009) | National Eye Institute (NEI) | 2004-12-09 |
| Study of Talaporfin Sodium Photodynamic Therapy to Treat Advanced Age Related Macular Disease (NCT00102115) | Light Sciences LLC | 2004-12-01 |
| Tracking Optical Coherence Tomography (NCT00343603) | University of Pittsburgh | 2004-10-01 |
| MSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With "Wet" Age-Related Macular Degeneration (AMD) (NCT00094120) | Genaera Corporation | 2004-10-01 |
| Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System (NCT00100087) | Theragenics Corporation | 2004-10-01 |
| Open Label Study for the Evaluation of Tolerability of Five Dose Levels of Cand5 (NCT00722384) | OPKO Health, Inc. | 2004-08-01 |
| A Safety and Efficacy Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular Degeneration (NCT00089830) | Genaera Corporation | 2004-08-01 |
| A Study of rhuFab V2 (Ranibizumab) in Subjects With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD) (NCT00090623) | Genentech, Inc. | 2004-08-01 |
| Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration) (NCT00150202) | Pfizer | 2004-07-01 |
| Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD) (NCT00088192) | Eyetech Pharmaceuticals | 2004-07-01 |
| Pegaptanib Sodium on Foveal Thickening in Patients With Exudative Subfoveal Age-Related Macular Degeneration (AMD) (NCT00087763) | Eyetech Pharmaceuticals | 2004-03-01 |
| Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration (NCT00220805) | Grifols Therapeutics LLC | 2004-01-01 |
| Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders (NCT00071227) | National Eye Institute (NEI) | 2003-10-15 |
| Open-Label Posterior Juxtascleral Injections of Anecortave Acetate 15mg Dose for Long Term Use in Patients With AMD (NCT00065728) | Alcon Research | 2003-06-01 |
| Effect of DHA Supplements on Macular Function in Patients With Stargardt Macular Dystrophy and Stargardt-like Macular Dystrophy (NCT00060749) | National Eye Institute (NEI) | 2003-05-05 |
| A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration (NCT00061594) | Genentech, Inc. | 2003-05-01 |